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Abstract
Distinction  between  true  negative  and  depressive
symptoms in schizophrenia is difficult. In the present
study we seek to establish the psychological profile of
depression-prone  schizophrenic  patients.  We  ad-
dressed the issue by comparing the expression of psy-
chological  indices,  such  as  the  feelings  of  being  in
control of events, anxiety, mood, and the style of cop-
ing with stress in depressive and non-depressive schiz-
ophrenics. We also analyzed the strength of the associ-
ation of these indices with the presence of depressive
symptoms. a total of 49 patients (18 women and 31
men, aged 23-59) were enrolled into the study, consist-
ing of a self-reported psychometric survey. We found
that the prevalence of clinically significant depression
in schizophrenic patients was 61%. the factors which
contributed to the intensification of depressive symp-
toms  were  the  external  locus  of  control,  anxiety,
gloomy mood, and the emotion-oriented coping with
stress. We conclude that psychological testing may dis-
cern  those  schizophrenic  patients  who  would  be  at
risk of depression development and may help separate
the blurred boundaries between depressive and nega-
tive symptoms of schizophrenia. 
Key words: anxiety,depression,locusof control,schizo  -
  phrenia, stress
IntRoDUctIon
negative symptoms in schizophrenia, which appear to
reflect a diminution of normal functions, such as apa-
thy, lack of emotion, or poor social functioning, are
similar to those in depression [1]. It is commonly held
that depressive symptoms are frequent among schizo-
phrenics, with the broad frequency oscillating between
10-75% [2-4]. such symptoms often are related to sui-
cidal thoughts in schizophrenia [5, 6]. so many as 2-
13% of schizophrenics eventually commit suicide and
most  of  them  experience  depressive  symptoms  at
some point of life, especially the feelings of helpless-
ness and loss [7, 8]. Depressive symptoms often con-
tribute  to  schizophrenia  exacerbation  [9]  and,  when
present at initial admission to hospital, may augur a
quick relapse [10]; all of which makes the recognition
and  treatment  of  depression  of  paramount  impor-
tance  in  schizophrenia.  the  large  scatter  in  the  fre-
quency  of  depression  in  schizophrenics  above  out-
lined seems to have reflected the ambiguity of distin-
guishing  between  the  negative  symptoms  of  schizo-
phrenia and those of depression. siris & Bench [4] ar-
gued that the ascribing symptoms to one or the other
condition should be based on the nature of affective
disorder  present,  with  sadness  predominating  in  de-
pression and apathy in schizophrenia. apart from the
subtle  difference  between  these  two  affective  states,
this criterion is not universally accepted. 
From the clinical standpoint it seems worthwhile to
establish a psychological profile of the schizophrenic
who  might  be  vulnerable  to  depression  during  the
course of his disease. In the present study, therefore,
we seek to determine the association of some psycho-
logical indices, such as the locus of control, anxiety,
mood, and the strategy of coping with stress, all of
which  underlie  changes  in  affective  state,  with  the
presence of depression in schizophrenic patients. We
addressed  the  issue  by  comparing  the  expression  of
these indices, as assessed by psychometric tools, in de-
pressive  and  non-depressive  schizophrenics.  overall,
the study demonstrates that the assessment of the psy-
chological indices could help recognize the appearance
of depression in schizophrenia.
MatERIaL anD MEtHoDs
the study was carried out in accord with the ethical
principles set in the Declaration of Helsinki for hu-
man experimentation and was approved by an institu-
tional Research Review committee. subjects who were
enrolled into the study gave informed consent after
being informed about the aim of the study and the
psychometric methods applied. no incentive was of-
fered for enrolment into the study. 
PatIEnts
a  total  of  49  subjects  undergoing  psychiatric  treat-
ment and rehabilitation participated in the study; mean
age 41.6 ﾱ11.0(sD), range 23-59 years, F/M – 18/31.
all subjects were diagnosed with paranoid schizophre-
nia (F20.0 according to IcD-10). the mean duration
of the disease was 12.0 ﾱ 7.9 years from the time of
diagnosis. the inclusion criterion was that the patient
be no less than 1 year from the beginning of an acute
phase of the disease. the patients were in remission
during the study, remaining on standard doses of the
antipsychotic  drugs  risperidone  and  olanzapine.  the
exclusion criteria were an active schizoaffective disor-
der and pharmacological or otherwise antidepressive
treatment. the educational status of the enrolled pa-
tients was as follows: 6 persons with primary educa-
tion (12.2%), 17 with vocational education (34.7%), 21
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versity education (10.2%). With regard to the marital
status,  30  persons  were  single  (61.2%),  9  married
(18.4%), 7 separated or divorced (14.3%), and 3 pa-
tients were widowed (6.1%). the study was conducted
during January - May 2009. 
PsycHoMEtRIc tooLs
Each patient was given a set of questionnaires, joint
together in this particular order: the Beck Depression
Inventory  (BDI-II),  the  Drwal  Delta  Inventory
(DDI), the state-trait anxiety Inventory (staI), the
UWIst  Mood  adjective  check  List  (UMacL),  and
the coping Inventory for stressful situations (cIss). 
the BDI-II is an instrument which assesses the in-
tensity of depressive symptoms [11]. the score range
is 0-63, and a score of ≥12 points was considered as
suggestive of the presence of clinically significant de-
pressive symptoms intensity. the DDI assesses the lo-
cus of control [12]. the questionnaire consists of 24
affirmative  sentences  requiring  a  “true  or  false”  an-
swer. Fourteen sentences pertain to one’s conviction
regarding the internal or external locus of control, and
the remaining 10 assess the possible impact of a ten-
dency to exaggerate oneself positive image; the latter
questions  are  based  on  those  found  in  the  validity
scales  of  personality  inventories,  in  particular  the
EPQ-R lie scale. a high score in the DDI points to
the external locus of control. the staI consists of
two  subscales  to  assess  the  levels  of  state  and  trait
anxieties [13]. the higher the score in a given scale,
the higher is the anxiety level. For the assessment of
mood,  the  UMacL  was  used  [14].  this  instrument
consists  of  three  subscales:  tense  arousal,  energetic
arousal, and hedonic tone. the UMacL includes 29
adjectives, with which one describes mood. the last
instrument used in the study was the cIss which was
created by Endler & Parker [15]. the inventory con-
sists of 48 items, which were assigned to the following
subscales: task-oriented, emotion-oriented, and avoid-
ance-oriented styles; the latter divided into the engag-
ing in substitutional activities and the seeking of social
interaction. the time for completion of the question-
naires was 35-45 min.
statIstIcaL EvaLUatIon
Data are presented as means ﾱsD of raw scores. Dif-
ferences in the mean group scores between patients
with  and  without  depressive  symptoms  were  com-
pared with an unpaired t-test. Pearson’s correlation co-
efficients  were  used  to  assess  the  relationships  be-
tween depressive symptoms and psychological indices
studied. a P value < 0.05 was considered statistically
significant. 
REsULts
there  were  30  (61%)  schizophrenic  patients  who
showed enhanced intensity of depressive symptoms,
exceeding the 12 point cut-off mark in the BDI-II.
the  mean  score  for  depressive  symptoms  in  this
group  of  patients  was  23.3  ﾱ  8.7  points,  indicating
mild-to-moderate  intensity  of  depressive  symptoms,
which starkly contrasted the 5.7 ﾱ 3.3 points in the
non-depressive  group  of  the  remaining  19  subjects
(P<0.05). there were no characteristic features which
could distinguish depressive vs. non-depressive schizo-
phrenic patients regarding the age, 42.1 ﾱ 10.6 vs. 40.7
ﾱ11.8 years, the gender, F/M -11/19 vs. 7/12, and the
disease duration 11.1 ﾱ 6.7 vs. 13.5 ﾱ 9.5 years, re-
spectively. nor were there major differences in the ed-
ucational or marital status between the two groups.
However,  a  number  of  psychological  indices,  as
presented in table 1, differed appreciably between de-
pressive  and  non-depressive  patients.  the  locus  of
control was significantly more often placed externally
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Table 1. Psychological indices in depressive and non-depressive schizophrenic patients.
Depressive Non-depressive P
Depressive symptoms 23.3 ﾱ 8.7 5.7 ﾱ 3.3 0.001
External locus of control 6.9 ﾱ 3.1 4.7 ﾱ 2.8 0.017
Anxiety
state  52.1 ﾱ 9.6 35.3 ﾱ 7.5 0.001
trait  54.3 ﾱ 8.6 39.3 ﾱ 7.9 0.001
Mood
tense arousal 23.2 ﾱ 4.1 17.0 ﾱ 4.7 0.001
Energetic arousal 24.5 ﾱ 4.5 30.1 ﾱ 4.2 0.001
Hedonic tone 23.6 ﾱ 4.5 32.6 ﾱ 4.1 0.001
Coping with stress
task-oriented 50.8 ﾱ 10.0 59.2 ﾱ 10.3 0.007
avoidance-oriented 47.5 ﾱ 7.6 48.5 ﾱ 6.4 0.646
substitutional activities 23.6 ﾱ 4.3 22.3 ﾱ 4.2 0.317
social interaction 15.1 ﾱ 3.0 16.7 ﾱ 3.1 0.074
Emotion-oriented 50.3 ﾱ 7.4 39.4 ﾱ 9.2 0.001
values are means ﾱsD of raw scores.
6) Pokorski##_Umbruchvorlage  14.11.11  11:27  Seite 550in the depressive group; 6.9 ﾱ 3.1 vs. 4.7 ﾱ 2.8 points
in  the  non-depressed  (P<0.02;  DDI  Questionnaire).
the levels of both state and trait anxieties were re-
markably higher in the depressive than in non-depres-
sive schizophrenics; 52.1 ﾱ 9.6 and 54.3 ﾱ 8.6 vs. 35.3
ﾱ  7.5  and  39.3  ﾱ  7.9  points,  respectively  (P<0.001;
staI  questionnaire).  the  depressive  schizophrenics
also  displayed  the  appreciably  enhanced  levels  of
moody tense arousal and emotion-oriented strategies
of coping with stressful situations; both having nega-
tive  psychological  connotations  (UMacL  and  cIss
questionnaires).  By  contrast,  the  positively  connoted
energetic arousal and hedonic tone as well as task-ori-
ented coping with stress were decreased. all these data
are summarized in table 1. 
table 2 shows the results of analyses of the rela-
tionships between the intensity of depressive symp-
toms, as found in the BDI-II, and the psychological
indices  studied.  Increasing  intensity  of  depressive
symptoms was positively related to the external locus
of control, the anxiety traits, and tense arousal, where-
as negative relations to depressive symptoms were at-
tributed to energetic arousal and hedonic tone.
DIscUssIon
the study demonstrates that the external placement of
the locus of control, enhanced state and trait anxieties
and tense arousal, and worsened mood are the cogent
signs of depression in schizophrenic patients. More-
over, an increase in these indices may presage the in-
tensification  of  depression.  the  study  also  demon-
strates a substantial, over 60% incidence of depressive
symptoms in schizophrenics. the latter finding is at
variance with a report showing a 13% incidence of de-
pression  among  schizophrenics  [16].  In  that  study,
however, a 17 point cut-off level, higher than that in
our study, was used in the BDI-II to define the pres-
ence of depressive symptoms. aside from the percent-
age differences concerning the prevalence of depres-
sion in schizophrenics, which are explicable by differ-
ent populations and methodologies employed, there is
a consensus that depression is a frequent and aggra-
vating accompaniment of schizophrenia. Mulholland
& cooper [3] have emphasized the fact that depres-
sion may be a prodromal symptom that precedes the
acute  phase  of  schizophrenia.  Herz  &  Melville  [17]
have reported that as many as 60% of patients and
75% of their family members pointed to depression as
a factor preceding relapse. Depression may be present
in both chronic and acute phases of the disease [18].
Depression interferes with the course of the disease,
leading to exacerbations, and necessitates alterations in
the treatment regimen [4, 10], let alone being the ma-
jor cause of suicidal attempts. Mulholland & cooper
[3] have reported that approximately 10% of schizo-
phrenics die by suicide, and what is significant, most
of them had had depressive episodes in their case his-
tories  or  had  exhibited  signs  of  depression  during
contacts with the medical personnel.
sands & Harrow [19] have carried out a longitudi-
nal study which was focused on describing differences
between  depression  in  schizophrenic  patients  and
schizoaffective disorders. they also tackle the issues of
whether some schizophrenics would be susceptible to
depression and of the relationship between depression
and social adjustment after discharge from the hospital
in schizophrenia sufferers. the study included patients
diagnosed with schizophrenia and depression, schizo  -
affective disorders of depressive type, psychoses com-
bined  with  depression,  and  non-psychotic  patients
with depression. the authors show that 30% of schiz-
ophrenics had depressive symptoms at 4.5 years and
40% had such symptoms at 7.5 years into the disease.
Depression  in  schizophrenia  was  associated  with
worse than that in the other conditions life adjustment
after  discharge,  such  as  unemployment,  low  activity,
general lack of satisfaction, suicidal tendencies, and a
large number of subsequent re-hospitalizations. Fur-
thermore, some schizophrenics were more susceptible
to depressive symptoms than others many years after
the acute phase of the illness, but neither the rate nor
severity of depressive symptoms could distinguish de-
pression  in  schizophrenia  from  schizo-depressive  or
major  depressive  disorders.  In  the  present  study,  al-
though we did not resolve the underlying mechanisms
of  the  susceptibility  to  depression  in  schizophrenia,
we believe we have shown that psychological assess-
ment  is  capable  of  sorting  out  a  subset  of  schizo-
phrenic patients prone to the development of depres-
sion, allowing therefore for timely undertaking clini-
cally significant countermeasures.
this study has limitations. a caution should be ex-
ercised in the interpretation of the BDI-II used in the
present study to measure the intensity of depressive
symptoms. although this inventory has been shown to
be  well  suited  for  the  identification  of  depressive
symptoms in stable, chronic schizophrenia [20] as well
as other psychiatric patients [21], the results might not
be replicable with other inventories of the kind. How-
ever,  the  nature  of  depressive  symptoms  in  schizo-
phrenic patients during remission is mainly associated
with  psychological  factors,  as  opposed  to  the  acute
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Table  2.  associations  between  the  intensity  of  depressive
symptoms  and  psychological  indices  assessed  by  Pearson’s
coefficients.
Correlation with depressive 
symptoms
External locus of control r = 0.42, P = 0.002
Anxiety
state  r = 0.72, P = 0.001
trait anxiety r = 0.71, P = 0.001
Mood
tense arousal r = 0.63, P = 0.001
Energetic arousal r = -0.73, P = 0.001
Hedonic tone r = -0.64, P = 0.001
Coping with stress
task-oriented r = -0.29, P = 0.043
avoidance-oriented r = -0.13, P = 0.387
substitutional activities r = 0.10, P = 0.509
social interaction r = -0.32, P = 0.027
Emotion-oriented r = 0.68, P = 0.001
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phase, in which the depressive symptoms are of the
more classical biological type, which can be better de-
tected, for instance, with the Hamilton Rating scale
for  Depression.  consequently,  one  can  assume  that
the BDI-II gave a reasonable insight into the occur-
rence  of  depressive  symptoms  in  our  patients.  Fur-
thermore, a relatively weak relationship between the
external locus of control and depressive symptoms in-
tensity may stem from the fact that the locus of con-
trol may be assumed a personality dimension. on this
assumption, it would not be surprising that it would be
less expressed in schizophrenia the axial symptom of
which  is  personality  degradation.  therefore,  the  re-
sults on the locus of control above outlined should be
critically approached. the present study also was car-
ried out in patients with the paranoid type of schizo-
phrenia. the incidence of depressive symptoms and
also their relation to the variables tested may not nec-
essarily be applicable to other types of schizophrenia. 
In conclusion, the external placement of the locus
of control and the psychological indices typifying de-
pression may be helpful in resolving doubts about the
distinguishing  between  the  negative  and  depressive
symptoms of schizophrenia. as the presence of these
indices  likely  antecedes  the  development  of  depres-
sion,  we  submit  that  psychological  testing,  possibly
followed by behavioral therapy aimed at anxiety reduc-
tion, would help develop effective strategies to inter-
vene with the disease process and thus should be part
of health programs that address schizophrenia. 
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